Cancer Risk Factors
New cancer risk factors study findings reported from Nanjing Medical University
Published in Drug Law Weekly, March 24th, 2009
Current study results from the report, 'FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies,' have been published. According to a study from Nanjing, People's Republic of China, "FAS is a cell surface receptor involved in apoptotic signal transmission and plays important roles in the etiology of cancer. The -1377G >A and -670A >G polymorphisms of the FAS gene influence the FAS transcription and have been implicated in cancer risk."
"However, the results from the published studies on the association between these two FAS polymorphisms and cancer risk are conflicting. To derive a more precise estimation of association between...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-03-24)
More Articles from Drug Law Weekly
- Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
Anapol Schwartz Forms Consortium with Columbus, Ohio-Based Firm - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
Clark, Perdue & List Co., LPA Forms Consortium with Philadelphia-Based Firm - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
U.S. Supreme Court Vacates Third Circuit Decision in Anti-Depressant Suicide Case - Antares Pharma, Inc.
Antares Pharma to Host Fourth Quarter and Year-End 2008 Earnings Call - Antares Pharma, Inc.
Antares to Present at Cowen and Company 29th Annual Health Care Conference - Biologics
Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
